A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

BACKGROUND: Local recurrence and remote metastasis are major challenges to overcome in order to improve the survival of patients with cancer after surgery. Oncolytic viruses are a particularly attractive option for prevention of postsurgical disease as they offer a non-toxic treatment option that ca...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Main Authors: Ahmed, Jahangir, Chard, Louisa S, Yuan, Ming, Wang, Jiwei, Howells, Anwen, Li, Yuenan, Li, Haoze, Zhang, Zhongxian, Lu, Shuangshuang, Gao, Dongling, Wang, Pengju, Chu, Yongchao, Al Yaghchi, Chadwan, Schwartz, Joel, Alusi, Ghassan, Lemoine, Nicholas, Wang, Yaohe
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2020
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206973/
https://ncbi.nlm.nih.gov/pubmed/32217766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000415
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares